#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Infection in an immunocompromised host Albright's disease Oesophageal squamous cell carcinoma stage II Thalassaemia Extranodal marginal zone B-cell lymphoma (MALT type) Primary myelofibrosis Thrombocytosis Urethral valves Barth syndrome Dementia with Lewy bodies Immunoglobulin G4 related disease Vulval cancer Gastrointestinal disorder Pancreatic carcinoma metastatic Phenylketonuria More trials…

    Learn about Rare Diseases

    Splenic marginal zone lymphoma – Diagnostics Sjogren’s syndrome – Diagnostics Brain stem glioma – Trials in Disease Mantle cell lymphoma Biotinidase deficiency – Basic Information Sarcoma – Treatment Mantle cell lymphoma stage II Factor IX deficiency Synovial sarcoma metastatic – Trials in Disease Hereditary optic atrophy – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Treprostinil LVT-001 Aluminium Oxide Amivantamab Insulin Glargine Cefazolin Meclofenamate Sodium Valaciclovir Danicamtiv SKB410 Mk-4830 GUAIACOL Belzupacap Sarotalocan GSKVX000000034795 Sodium Cromoglicate Db-Oto-5 Mk-0482 Ketotifen Hydrogen Fumarate HYDROGEN PEROXIDE Paclitaxel More therapies…

    Learn about Your Condition

    Dementia with Lewy bodies Clostridium difficile colitis Hepatic angiosarcoma Venous thrombosis limb Lung transplant rejection Generalised anxiety disorder Diabetic autonomic neuropathy Trisomy 21 Dysmenorrhoea Carcinoid syndrome Soft tissue sarcoma Herpes zoster Peripheral ischaemia Osteoporosis Malabsorption More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Praglandia s.r.o.

Praglandia s.r.o.

Nadrazni 3368/30a, Smichov, Prague, 150 00, Czechia

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of ANB032, Betamethasone Dipropionate, and Hydrocortisone for Patients with Moderate to Severe Atopic Dermatitis

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Anb032
    • Betamethasone Dipropionate
    • Hydrocortisone
    Czechia Poland

  • Study on Atogepant for Treating Migraine in Patients: Evaluating Effectiveness and Safety

    Not recruiting

    3 1
    Investigated Diseases:
    • Migraine
    • Migraine with aura
    • Migraine without aura
    Investigated Drugs:
    • Atogepant
    Belgium Czechia Germany Hungary Italy Poland +4

  • Study on Rezpegaldesleukin for Treating Moderate-to-Severe Atopic Dermatitis in Adults

    Not recruiting

    2 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Rezpegaldesleukin
    Bulgaria Croatia Czechia Germany Hungary Poland +1

  • Study on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Pimecrolimus
    • Tacrolimus
    • Amlitelimab
    Bulgaria Czechia Denmark Italy Portugal Spain +1

  • Study on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis Using Topical Corticosteroids

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Pimecrolimus
    • Tacrolimus
    • Amlitelimab
    Bulgaria Czechia France Germany Italy Spain

  • Study on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Pimecrolimus
    • Tacrolimus
    • Amlitelimab
    Bulgaria Czechia Denmark France Germany Greece +5

  • Study on Long-Term Safety of GSK1070806 for Patients with Moderate to Severe Atopic Dermatitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Humanised Igg1 Kappa Monoclonal Antibody Against Interleukin 18
    Bulgaria Czechia France Germany Greece Italy +2

  • Study Comparing Atogepant and Topiramate for Preventive Treatment in Adults with Migraine

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Migraine
    • Migraine with aura
    • Migraine without aura
    Investigated Drugs:
    • Atogepant
    • Topiramate
    Austria Belgium Czechia France Germany Hungary +3

  • Study on the Effects of LEO 138559 for Adults with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Humanised Igg1 Monoclonal Antibody Against Interleukin 22 Receptor Subunit Alpha
    Czechia France Germany Hungary Poland Romania +1

  • Study on the Effectiveness and Safety of Methotrexate Compared to Placebo for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Desoximetasone
    • Folic Acid
    • Tacrolimus
    Czechia France Italy Poland
Previous Page
1 … 3 4 5 6
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!